Cargando…
Case Report: Severe thrombocytopenia induced by adalimumab in rheumatoid arthritis: A case report and literature review
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by persistent joint inflammation. In recent decades, biological agents such as anti-tumor necrosis factor-α (TNF-α) drugs have been applied in the treatment of RA and it achieved great improvement. The treatment has its side e...
Autores principales: | Liao, Tiantian, Li, Mengqing, Yuan, Tian, Hong, Qifu, Zeng, Yu, Yu, Dan, Yu, Qiong, Yu, Limei, Pu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640920/ https://www.ncbi.nlm.nih.gov/pubmed/36386149 http://dx.doi.org/10.3389/fphar.2022.1041884 |
Ejemplares similares
-
Adalimumab-Induced Erythema Multiforme in a Patient With Rheumatoid Arthritis: A Case Report
por: Mohammed, Jinan Q, et al.
Publicado: (2022) -
Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia
por: Tu, Xiaofang, et al.
Publicado: (2022) -
Adalimumab induced mononeuritis multiplex in a patient with refractory rheumatoid arthritis: a case report
por: Makol, Ashima, et al.
Publicado: (2008) -
Traditional Tibetan medicine: therapeutic potential in rheumatoid arthritis
por: Yu, Liqiong, et al.
Publicado: (2022) -
Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis
por: Gissel, C., et al.
Publicado: (2017)